These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20039512)

  • 1. Management of in-stent restenosis in a patient with a drug eluting stent on hemodialysis awaiting renal transplantation.
    Natarajan D; Sarin A; Upadhyaya S
    Indian Heart J; 2009; 61(2):214-5. PubMed ID: 20039512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side balloon stenting of the left main bifurcation: a three-year angiographic follow-up.
    Latif F; Heldman AW; Hennebry TA
    J Interv Cardiol; 2009 Dec; 22(6):547-9. PubMed ID: 19735474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
    Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW
    Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohort.
    Beijk MA; Claessen BE; Koch KT; Henriques JP; Baan J; Vis MM; Meesterman M; Tijssen JG; Piek JJ; de Winter RJ
    Int J Cardiol; 2010 Dec; 145(3):608-9. PubMed ID: 20850881
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left main coronary artery stenosis treatment with two paclitaxel-eluting stents in a patient with cardiac allograft vasculopathy.
    Martínez-Ríos MA; Méndez-Ortíz A; Gaspar J; Barragán-García R; Fernández-de-la-Reguera G; González-Quesada CJ
    Arch Cardiol Mex; 2008; 78(4):407-12. PubMed ID: 19205549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
    Yarkoni A; Brodsky A; Sabapathy R; Pershad A
    Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-eluting stent implantation for unprotected left main coronary artery disease: immediate and long-term outcomes].
    Zhang LT; Yuan Y; Huang XS; Feng L; Liu WQ; Han Y; Zhang J; Deng ZH; Dong JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2257-9. PubMed ID: 19114374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In-stent-stenosis of a bare-metal stent 11 years after its implantation].
    Skarlos AC; Zahn R; Zeymer U
    Dtsch Med Wochenschr; 2010 May; 135(21):1067-70. PubMed ID: 20486056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bare metal stent implantation for in-stent restenosis with a drug-eluting stent.
    Matsuoka H; Kawakami H; Ohshita A; Kohno T; Shigemi S; Okayama H; Higaki J
    J Cardiol; 2010 Jan; 55(1):135-8. PubMed ID: 20122561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
    Tomai F; Reimers B; De Luca L; Galassi AR; Gaspardone A; Ghini AS; Ferrero V; Favero L; Gioffrè G; Prati F; Tamburino C; Ribichini F
    Diabetes Care; 2008 Jan; 31(1):15-9. PubMed ID: 17909090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
    Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
    N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
    Krucoff MW; Kereiakes DJ; Petersen JL; Mehran R; Hasselblad V; Lansky AJ; Fitzgerald PJ; Garg J; Turco MA; Simonton CA; Verheye S; Dubois CL; Gammon R; Batchelor WB; O'Shaughnessy CD; Hermiller JB; Schofer J; Buchbinder M; Wijns W;
    J Am Coll Cardiol; 2008 Apr; 51(16):1543-52. PubMed ID: 18420096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
    Byrne R; Iijima R; Mehilli J; Pache J; Schulz S; Schömig A; Kastrati A
    Rev Esp Cardiol; 2008 Nov; 61(11):1134-9. PubMed ID: 19000488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.